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ABSTRACT
Background: Influenza virus is a highly prevalent respiratory virus responsible for annual 
epidemics as well as occasional pandemics. Extrarespiratory complications have been 
described, including neurological as well as ocular complications. This study examines the 
permissiveness of a panel of human neuronal and ocular cells to infection with the recent 
influenza A/H1N1pdm virus and cellular expression of α2,3- and α2,6-linked sialic acids.
Methods: Studied cells included the human neuroblastoma cell lines SH-SY5YplkOB1 
and SK-N-SH, a glioblastoma patient isolate GBM847a, the human uveal melanoma cell 
lines OCM3, OMM1.5 and 92-1, and, as controls, Madin-Darby canine kidney (MDCK) and 
16HBE human bronchial epithelial cells. Cells were infected with influenza A/H1N1pdm 
virus and their permissiveness was assessed via nucleoprotein (NP) staining analyzed by 
fluorescence microscopy. Additionally, cells were stained for the presence of α2,3- and 
α2,6-linked sialic acids and examined by fluorescence microscopy as well.
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Results: All tested human cell types were permissive for influenza A/H1N1pdm infection. 
Furthermore, selected neuronal and ocular cells expressed α2,3- and/or α2,6-linked sialic 
acids.
Discussion: This study demonstrates the permissiveness of a panel of human neuronal 
and ocular cells for the recent influenza A/H1N1pdm virus and expression of α2,3- and α2,6-
linked sialic acids. These data contribute to clinical as well as experimental evidence indi-
cating that, apart from respiratory cells, influenza virus can infect other cells and, thus, 
may give rise to extrarespiratory complications.
ABBREVIATIONS
CNS: Central Nervous System, DAPI: 4’,6-diamidino-2-phenylindole, DMEM: Dulbecco’s 
Modified Eagle Medium; FBS: Fetal Bovine Serum; FCS: Fetal Calf Serum; IF: Immunoflu-
orescence; IMDM: Iscove’s Modified Dulbecco’s Medium; LAS: Leica Application Suite; LM: 
Light Microscopy; MAL-I: Maackia Amurensis Lectin I; MAL-II: Maackia Amurensis Lectin II; 
MDCK: Madin-Darby Canine Kidney; MEM: Minimum Essential Medium; MOI: Multiplicity 
of Infection; NP: Nucleoprotein; ORN: Olfactory Receptor Neuron; PML: Progressive Multi-
focal Leukoencephalopathy; PVOD: Post-viral Olfactory Dysfunction; SNA: Sambucus Nigra 




Influenza virus is one of the most prevalent respiratory viruses and responsible for annual 
epidemics as well as occasional pandemics with sometimes devastating outcomes. The 
virus is classically considered to mainly infect the upper, and occasionally lower, respira-
tory tract, clinically giving rise to upper respiratory symptoms and pneumonias.
In addition to respiratory disease, extrarespiratory complications have been described, 
including neurological as well as ocular complications. Furthermore, associations between 
respiratory viral infections and the development of neuroinflammatory and neurodegener-
ative diseases have been postulated [1-6].
Whether or not extrarespiratory complications arise likely depends upon a delicate 
virus-host interplay involving distinct receptor interactions. In this respect, several viruses 
associated with central nervous system (CNS) and/or ocular complications, including 
adenoviruses, JC virus and influenza virus, interact with distinct sialic acids on host cell 
membranes [2,7-9]. Influenza viruses have, in terms of virus-host interactions, been classified 
into viruses that circulate in avian hosts and viruses circulating in other hosts including 
humans. In addition, viruses with low or high pathogenicity are distinguished [8]. Host cell 
binding and subsequent infection of cells by human influenza viruses are predominantly 
mediated by α2,6-linked sialic acids, whereas avian influenza viruses mostly interact with 
α2,3-linked sialic acids [8,9]. In this regard, the ability of avian H5N1 viruses to be transferred 
to -and among- human hosts, as well as issues involving receptor specificity and viral path-
ogenicity, have been the subject of recent investigation [10,11].
Neurological as well as ocular, often conjunctival, extrarespiratory complications have 
been described for both human and avian influenza viruses, although reported incidence 
rates for virus subtypes might vary [1,2,12-25]. The pathogenesis of these complications can, at 
least partly, be explained by receptor interactions. Upper respiratory tract epithelial cells 
mostly express α2,6-linked sialic acids, whereas cells lining the surfaces of the lower respira-
tory tract and eyes predominantly express α2,3-linked sialic acids, which might correlate 
with the observed clinical symptoms upon influenza virus infection in vivo [2,8,9]. The CNS 
potentially expresses both sialic acid subtypes as neurotropic viruses including JC virus, 
which can cause the demyelinating disorder progressive multifocal leukoencephalopathy 
(PML), have been shown to interact with α2,6- and α2,3-linked sialic acids [7]. Methods 
aimed at the mapping of sialic acids in several brain regions in vivo are being developed [7].
With respect to CNS entry routes, animal models have demonstrated that influenza 
viruses can infect the CNS via the olfactory system, likely following infection of olfactory 
receptor neurons (ORNs) within the olfactory neuroepithelium [6,26-33]. In humans, the syn-
drome of post-viral olfactory dysfunction (PVOD), consisting of olfactory loss and/or histo-
logical alterations in the olfactory epithelium, has been described following infections with 
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respiratory viruses [34-36]. With respect to sialic-acid receptor expression patterns on ORNs, 
it has been shown that mouse ORNs can be stained with a pattern of lectins which recog-
nize galactose, N-acetylgalactosamine and sialic acids, although subtypes and expression 
on human ORNs have not been determined [37].
This study examines the permissiveness of a panel of human neuronal and ocular cells 
for the recent influenza A/H1N1pdm virus, which has been associated with neurological as 
well as ocular complications [2,12,15-18], and analyzes sialic-acid expression patterns on these 
cells. Examined neuronal cells include the human neuroblastoma cell line SH-SY5YplkOB1, 
containing an empty plasmid, which was previously shown to be permissive for influenza 
A/H5N1 and seasonal H1N1 viruses and to express both α2,3- and α2,6-linked sialic acids 
[38]. The same study analyzed the permissiveness and sialic-acid expression of the human 
glioblastoma cell lines T98G and U87MG, whereas another study examined the permissive-
ness of the glioblastoma cell line GBM8401 to influenza B virus and, in the current study, we 
used the human glioblastoma patient isolate GBM847a [38,39]. The human neuroblastoma 
cell line, SK-N-SH, has been used to study the neuronal tropism of herpes viruses [40].
Examined ocular cells include the human uveal melanoma cell lines OCM3, OMM1.5 and 
92-1. OCM3 and 92-1 cells were derived from primary tumors, and OMM1.5 cells from a 
metastasis [41]. Located within the eye, the uvea consists of the choroid, a cell layer neigh-
boring the retina, capillary bodies and iris. The choroid provides nutrients and oxygen to 
the retina and uveal cells arise from the neuroepithelium or neural crest. In addition, these 
“non-neuronal” cells have been shown to have the capacity to differentiate to cells with a 
neuronal phenotype under appropriate culture conditions [42]. For these reasons, and par-
ticularly because of their close proximity to a cranial sensory nerve, i.e. the optic nerve, 
uveal cells may resemble ORNs.
With respect to the direct involvement of uveal melanoma cells in ocular complications, 
uveitis or uveal disorders have been associated with several viruses, including influenza 
virus [24]. Although a recent study showed H5N1 virus infection of ciliary process epithelial 
cells in ferrets, the permissiveness of human uveal cells to influenza virus infection and 
sialic-acid receptor expression patterns remain in question [2,43]. By analyzing the permis-
siveness to influenza A/H1N1pdm virus and sialic-acid receptor expression patterns of this 
panel of human neuronal and ocular cells in vitro, this study contributes to knowledge con-





Human influenza A/CA/7/2009 (A/H1N1pdm) virus was propagated, and the TCID50 deter-
mined, in Madin-Darby canine kidney cells, as previously described [44,45]. The human neu-
roblastoma cell line SH-SY5YplkOB1, containing an empty plasmid, was a kind gift from Dr. 
J. Marie Hardwick (Department of Molecular Microbiology and Immunology, Johns Hop-
kins Bloomberg School of Public Health, Baltimore, Maryland, USA). The human neuro-
blastoma cell line SK-N-SH was a kind gift from Dr. Jelena Levitskaya (Department of Molec-
ular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 
Baltimore, Maryland, USA). The human glioblastoma patient isolate GBM847a was a kind 
gift from Dr. Alfredo Quinones-Hinojosa (Department of Neurosurgery, Johns Hopkins Uni-
versity, Baltimore, Maryland, USA). These cells were cultured using a mixture of Dulbecco’s 
Modified Eagle Medium or Minimum Essential Medium (DMEM/MEM) (Life Technologies, 
Grand Island, New York, USA) and Ham’s F12 medium (Life Technologies) supplemented 
with 10% fetal calf serum or fetal bovine serum (FCS/FBS), 100 U/mL penicillin and 0.1 mg/
mL streptomycin (Life Technologies or PAA Labs, Pasching, Austria). Human uveal mela-
noma cell lines OCM3, OMM1.5 and 92-1 were a kind gift from Dr. Jelena Levitskaya and cul-
tured using Iscove’s Modified Dulbecco’s Medium (IMDM, Life Technologies) supplemented 
with 10% FCS/FBS and 100 U/mL penicillin and 0.1 mg/mL streptomycin.
Madin-Darby canine kidney (MDCK) cells were cultured as described previously [44,45] or 
using Episerf medium (Life Technologies) supplemented with 25 mM Hepes (Life Technol-
ogies), 750 mg/L sodium bicarbonate (Life Technologies), 100 U/mL penicillin and 0.1 mg/
mL streptomycin.
16HBE human bronchial epithelial cells were a kind gift from Dr. Herman Meurs (Depart-
ment of Molecular Pharmacology, University of Groningen, The Netherlands). The cells 
were cultured using MEM, supplemented with 10% FBS, 2 mM L-glutamine, 1000 U/mL pen-
icillin, 1 mg/mL streptomycin, 56 μg/mL gentamicin (Life Technologies) and 1.5 mg/mL fun-
gizone (Life Technologies).
Cellular permissiveness
Cells were cultured on acid-washed cover slips and infected with influenza A/H1N1pdm 
virus at a multiplicity of infection (MOI) of 5 TCID50/cell for 1.5 hr at 37°C. Infection medium 
consisted of DMEM supplemented with 2 mM L-glutamine, 100 U/mL penicillin, 0.1 mg/mL 
streptomycin and 4 μg/mL N-acetyl-trypsin. Following incubation at 37°C for 24 hr cells 
were fixed with 4% paraformaldehyde and stained for influenza nucleoprotein (NP), using 
mouse anti-NP [44,45] as a primary antibody and AlexaFluor 488 donkey anti-mouse (Life 
Technologies) as a secondary antibody, and embedded in mounting medium containing 
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4,6-diamidino-2-phenylindole (DAPI, Life Technologies or Vector Laboratories, Burlingame, 
California, USA). Controls consisted of similarly stained uninfected cells. Staining was ana-
lyzed by fluorescence microscopy using a Nikon Upright E800 microscope (Nikon, Chiyoda, 
Tokio, Japan) and Image-Pro Plus software (Media Cybernetics, Rockville, Maryland, USA).
Sialic-acid expression patterns
Cells cultured on acid-washed coverslips for 2 days at 37°C were fixed with 4% paraform-
aldehyde and stained with biotinylated Sambucus Nigra Lectin (SNA), recognizing α2,6-
linked sialic acids or biotinylated Maackia Amurensis Lectin I or II (MAL-I or –II), recognizing 
α2,3-linked sialic acids [46] followed by AlexaFluor 488 or 647 conjugated to streptavidin 
(Vector Laboratories) and embedded in mounting medium containing DAPI. Controls con-
sisted of cells stained with AlexaFluor-conjugated streptavidin alone. In addition, control 
human respiratory cells were incubated in 50 mU/mL neuraminidase from C. perfringens 
cleaving sialic acids on the cell surface in the order α2,3>α2,6>α2,8 (Sigma, St. Louis, Mis-
souri, USA) for 1 hr at 37°C prior to fixation and stained as above. Staining was analyzed 
by fluorescence microscopy, using a Nikon Upright E800 (see above) or Leica DM4000 B 




To assess the permissiveness of human neuronal and ocular cells to influenza A/H1N1pdm 
virus infection, cells were cultured on acid-washed coverslips, infected at MOI 5 TCID50/
mL, and incubated for 24 hr at 37°C. Cells were then stained for expression of influenza 
virus NP using a mouse anti-NP primary antibody and a donkey anti-mouse AlexaFluor 
488 secondary antibody. To control for nonspecific staining, uninfected cells were stained 
according to a similar protocol. MDCK cells served as a positive control. Results were ana-
lyzed by fluorescence microscopy.
All tested human neuronal and ocular cells were permissive for influenza A/H1N1pdm 
infection (Figure 1). Positive cells included the SH-SY5Y and SK-N-SH human neuroblas-
toma, GBM847 glioblastoma patient isolate, and OCM3, OMM1.5 and 92-1 human uveal 
melanoma cells. MDCK cells stained positive as well (data not shown).
Sialic-acid expression patterns
To assess sialic-acid expression patterns on human neuronal and ocular cells, cells were 
cultured on acid-washed coverslips and stained for the presence of specific sialic-acid 
linkage subtypes. To assess the expression of α2,6-linked sialic acids, cells were stained 
with biotinylated SNA and to examine the presence of α2,3-linked sialic acids, cells were 
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stained with MAL-I or MAL-II. Of the latter two lectins, MAL-I can be used to detect N-linked 
or core 2 O-linked glycans containing the trisaccharide Siaα2,3Galβ1,4GlcNAc and MAL-II 
to detect O-linked glycans containing the trisaccharide Siaα2,3Galβ1,3GalNAc [47]. To visu-
alize biotinylated lectin binding, cells were stained with AlexaFluor 488 or 647 conjugated 
to streptavidin. Internal controls consisted of cells stained with AlexaFluor-conjugated 
streptavidin alone. As an additional control, human bronchial epithelial cells were treated 
with neuraminidase prior to staining. Staining results were analyzed by fluorescence 
microscopy.
Neuronal and ocular cells expressed distinct sialic-acid subtypes as indicated by positive 
lectin-staining results. Positive signals for α2,3-linked sialic-acid staining were observed 
for SH-SY5Y human neuroblastoma and OCM3 cells (Figure 2). Likewise, OMM1.5 and 92-1 
human uveal melanoma cells stained positive for α2,3-linked sialic-acid (data not shown). 
The SK-N-SH human neuroblastoma cells and GBM847 patient isolate were not tested for 
α2,3-linked sialic-acid expression. In a similar fashion, positivity for α2,6-linked sialic-acid 
staining was demonstrated for SH-SY5Y and OCM3 cells (Figure 2). SK-N-SH human neuro-
blastoma, the GBM847 glioblastoma patient isolate, OMM1.5 and 92-1 human uveal mela-
noma cells also stained positive for α2,6-linked sialic-acid (data not shown). Human bron-
chial epithelial cells stained positive for α2,3-linked and, to a lesser extent, for α2,6-linked 
sialic acids. This staining was sensitive to treatment with neuraminidase from C. perfrin-
gens, underlining its specificity for sialic acid (Figure 3).
Figure 1: Permissiveness of human neuronal and ocular cells for influenza A/H1N1pdm virus. Cells were infected 
with influenza A/H1N1pdm virus at a MOI of 5 TCID50/mL and allowed to incubate for 24 hr. Following fixation, cells 
were stained with anti-NP primary and AlexaFluor-conjugated secondary antibodies, and embedded in mounting 
medium containing DAPI. Internal controls consisted of uninfected cells that were similarly stained. (LM: light 
microscopy, green: AlexaFluor 488; blue: DAPI, fluorescence microscope magnification: 100x).
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Figure 2: Sialic-acid expression on human neuronal and ocular cells. Following fixation, cells were stained with 
biotinylated lectins interacting with different sialic acid subtypes (SNA recognizing α2,6-linked sialic acids and 
MAL-I and -II recognizing α2,3-linked sialic acids) followed by staining with AlexaFluor-conjugated streptavidin, 
and embedded in mounting medium containing DAPI. Internal controls consisted of cells that were stained with 
streptavidin and DAPI alone. (red: AlexaFluor 647; blue: DAPI, fluorescence microscope magnification 200x).
160
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Figure 3: Sialic-acid expression on control human respiratory cells with and without neuraminidase treatment. 
Cells were treated with neuraminidase for 1 hr, fixed, and stained with biotinylated lectins interacting with different 
sialic acid subtypes (SNA recognizing α2,6-linked sialic acids and MAL-I and -II recognizing α2,3-linked sialic acids) 
followed by staining with AlexaFluor-conjugated streptavidin, and embedded in mounting medium containing 
DAPI. Controls consisted of cells that were not treated with neuraminidase and stained following a similar protocol. 
In both experimental settings, internal controls consisted of cells that were stained with streptavidin and DAPI 
alone. (N: neuraminidase; red: AlexaFluor 647; blue: DAPI, fluorescence microscope magnification 200x).
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DISCUSSION
Using a panel of different human neuronal, ocular and control cells, it was shown that 
these cells were permissive to influenza A/H1N1pdm virus infection and expressed α2,3- 
and/or α2,6-linked sialic acids. Although studied cell types are cell lines, they are of human 
origin and it will be interesting to see to which extent the current in vitro findings corre-
spond to the human in vivo situation.
The observed overall permissiveness as well as sialic-acid receptor expression data of 
neuronal cells are in agreement with the results of a previous study in which different 
human neuronal cells, including SH-SY5Y as well as astrocytic cells, were shown to be per-
missive for highly pathogenic avian influenza A/H5N1 as well as low-pathogenic seasonal 
H1N1 viruses and to express both α2,3- and α2,6-linked sialic acids [38]. In the present study, 
SH-SY5Y and SK-N-SH neuroblastoma cells, as well as a GBM847 glioblastoma patient iso-
late, were permissive for the influenza AH1N1pdm virus and expressed α2,6- and/or α2,3- 
linked sialic acids. 
With respect to ocular cells, previous studies have demonstrated the permissiveness of 
human corneal epithelial, trabecular meshwork, conjunctival epithelial and retinal pig-
ment epithelial cells to, at least specific avian, influenza viruses [2]. In terms of receptor 
specificities, the cornea and conjunctiva predominantly express α2,3-linked sialic acids, 
whereas the nasolacrimal duct expresses both α2,3- and α2,6- linked sialic acids [2]. In the 
current study, uveal melanoma cells were permissive for influenza A/H1N1pdm virus and 
expressed α2,6- and α2,3-linked sialic acids. Susceptibility to infection may be clinically 
relevant because uveal complications have been described for several viral infections, 
including infections with influenza virus [24].
HBE cells expressed α2,3-linked and, to a lesser extent, α2,6-linked sialic acids. This 
binding pattern is consistent with the notion that human bronchi, bridging the upper and 
lower respiratory tract, might express both sialic acid subtypes [2,48].
With respect to the pathogenesis of extrarespiratory complications of influenza in vivo, 
viral as well as host factors likely play a role. In the case of neurological infections, both 
axonal and hematogenous spread of viruses to the CNS has been described. Axonal spread 
likely depends upon the ability of a virus to infect specific neuronal cell types, such as 
ORNs, and hematogenous spread on its capacity to elicit a viremia. Both CNS entry path-
ways have previously been demonstrated to be linked to distinct viral pathogenicity pat-
terns [29]. With regard to ocular complications, similar virus-host interactions might play 
a role. In this respect, it has been demonstrated that influenza viruses, following ocular 
infection, can spread to other organ systems, including the respiratory tract [2].
The presence of influenza virus in the CNS in the context of apparent disseminated infec-
tions have been described for infection with avian H5N1 viruses, rendering hematogenous 
spread, at least for these viruses, a potential mechanism of viral dissemination to the CNS 
in humans [19-22]. Infection of ORNs and/or axonal spread along the olfactory nerve has been 
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described for several viruses, including H5N1 and H1N1 influenza strains, in animal models 
of infection [6,26-33]. However, the exact sialic-acid receptor expression patterns and permis-
siveness of human ORNs remain to be determined. Although this study did not include 
ORNs, uveal melanoma cells are peripheral cells with a close embryological and anatom-
ical linkage to the CNS and might resemble ORNs [42]. Using these cells, as well as several 
cells representing different CNS resident cell types, we have mimicked cell types ranging 
from the periphery to the CNS that might be encountered during axonal neuroinvasion, 
including invasion along the olfactory nerve. Receptor expression patterns on these cells 
might be of relevance to other viruses infecting the CNS and/or eyes, as adenoviruses and 
JC virus have been demonstrated to interact with sialic acids as well. 
The present study contributes to clinical and experimental data demonstrating that, 
apart from infection of the respiratory epithelium, respiratory viruses can infect other cell 
types that are exposed to transmitted aerosols as well, with the possibility to cause extra-
respiratory complications. It is plausible that respiratory viruses come into contact with 
ORNs or are deposited on ocular surfaces to extend infection, in conjunction with immuno-
logical and anatomical factors [2,26-28,49,50]. In this respect, it is noteworthy that several neu-
rodegenerative/neuroinflammatory diseases start with dysfunction of one or more sensory 
systems, such as the olfactory or optic system [5,51,52]. Therefore, the pathogenesis of extra-
respiratory complications and associated transmission routes deserve further investiga-
tion.
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